ProfileGDS4718 / 206534_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 40% 41% 34% 39% 40% 39% 38% 40% 31% 36% 36% 35% 45% 37% 39% 37% 33% 43% 46% 46% 39% 39% 36% 28% 39% 41% 41% 32% 35% 46% 45% 38% 41% 39% 39% 34% 45% 39% 37% 35% 41% 43% 36% 41% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9940240
GSM549102patient 115, normal, homogenized [OPG study]5.065441
GSM549104patient 119, normal, homogenized [OPG study]4.7105434
GSM549108patient 138, normal, homogenized [OPG study]4.9935239
GSM549119patient 077, normal, homogenized [OPG study]5.0118340
GSM549133patient 032, cancer, homogenized [OPG study]4.8894839
GSM549139patient 042, cancer, homogenized [OPG study]4.8979238
GSM549099patient 107, normal, homogenized [OPG study]5.0206940
GSM549109patient 139, normal, homogenized [OPG study]4.6148731
GSM549110patient 046, normal, homogenized [OPG study]4.7978536
GSM549114patient 063, normal, homogenized [OPG study]4.7402536
GSM549122patient 082, normal, homogenized [OPG study]4.7519335
GSM549134patient 033, cancer, homogenized [OPG study]5.2159445
GSM549136patient 036, cancer, homogenized [OPG study]4.8019337
GSM549140patient 044, cancer, homogenized [OPG study]4.9107739
GSM549111patient 047, normal, homogenized [OPG study]4.8027137
GSM549113patient 057, normal, homogenized [OPG study]4.6075933
GSM549132patient 031, cancer, homogenized [OPG study]5.1268443
GSM549137patient 038, cancer, homogenized [OPG study]5.2665546
GSM549142patient 047, cancer, homogenized [OPG study]5.4502646
GSM549100patient 110, normal, homogenized [OPG study]4.9739839
GSM549107patient 135, normal, homogenized [OPG study]4.9321739
GSM549115patient 068, normal, homogenized [OPG study]4.7499836
GSM549116patient 072, normal, homogenized [OPG study]4.4548528
GSM549120patient 078, normal, homogenized [OPG study]4.9459539
GSM549131patient 030, cancer, homogenized [OPG study]4.9736941
GSM549118patient 074, normal, homogenized [OPG study]5.048441
GSM549129patient 027, cancer, homogenized [OPG study]4.6541632
GSM549123patient 088, normal, homogenized [OPG study]4.7540135
GSM549124patient 006, cancer, homogenized [OPG study]5.3477546
GSM549126patient 015, cancer, homogenized [OPG study]5.2379645
GSM549128patient 025, cancer, homogenized [OPG study]4.8741638
GSM549103patient 117, normal, homogenized [OPG study]5.1131141
GSM549117patient 073, normal, homogenized [OPG study]4.9100839
GSM549138patient 041, cancer, homogenized [OPG study]4.9496539
GSM549141patient 045, cancer, homogenized [OPG study]4.6486734
GSM549130patient 028, cancer, homogenized [OPG study]5.2289145
GSM549101patient 111, normal, homogenized [OPG study]4.9727739
GSM549105patient 128, normal, homogenized [OPG study]4.8610637
GSM549106patient 134, normal, homogenized [OPG study]4.7022235
GSM549112patient 048, normal, homogenized [OPG study]5.0405241
GSM549125patient 011, cancer, homogenized [OPG study]5.1710343
GSM549127patient 024, cancer, homogenized [OPG study]4.8127736
GSM549135patient 035, cancer, homogenized [OPG study]5.0041341